Thank you, Chair,
Thank you all for taking the time to present. We have heard from other witnesses that a number of your organizations are doing great work, and they are asking for some of the same things as you are.
CFI, Mr. Phillipson, in my view is an absolute success story in Canada in the last number of years.
Mr. Andersson, you've spoken about the investments in research, and I know that Dr. McMillan and Mr. Tholl are involved in that as well.
The expansion of research has gone a long way in Canada. It has created a few problems too, almost an abundance of riches, in that there was a request from Monsieur Giroux that we go to 65% of indirect costs. If we go to 65% of indirect costs to the universities, the Heart and Stroke Foundation doesn't get indirect costs and it makes it more difficult for them to get funding. It's a matter of where we put our priorities. As a former executive director at the Heart and Stroke Foundation of Canada, Bill Tholl knows that and knows how that organization reformed itself in many ways to take advantage of CIHR in particular.
My question, first of all, to Mr. Phillipson is, if Canada hadn't invested, going back into the late 1990s, in research, in CFI and CIHR as well as in NSERC, SSHRC, and all of those things, what would it look like in Canada now? I think that's a good judge of how we should go forward in making these decisions.